170 likes | 172 Views
Performance report. Qtr3 2018/19 Jan 2019. Contents. Executive summary. Strategic highlights Approvals: timelines consistently being met for all but non-rec studies 74% of applicants rate our overall service highly slightly down on Qtr2 Transparency in Research survey published
E N D
Performance report Qtr3 2018/19 Jan 2019
Executive summary • Strategic highlights • Approvals: timelines consistently being met for all but non-rec studies • 74% of applicants rate our overall service highly slightly down on Qtr2 • Transparency in Research survey published • Combined ways of working (CWOW) pilot well received. 24 applications. 18 complete. • Significant progress made in aligning processes with 4 Nations • Successful REC Chairs day held • New IRAS progressing at pace, phase 2 case submitted. • Strategic challenges • Complexities arising from interoperability and multi stakeholder engagement are impacting on timelines for new IRAS development • Our ability to influence transparency agenda may be limited, HRA approach to be discussed at January Board • IT infrastructure replacement (future service programme) must be delivered by April 2020. HRA participates at Board level to mitigate this risk. • Budget pressure to year-end being actively managed - £50k - £100k.
Championing health and social care research • Transparency in Research survey published – 6th Dec • Transparency project communication management strategy drafted • Research integrity inquiry report vol 2 on Clinical Trials transparency published – HRA response well received by select committee and Ben Goldacre • Draft legal advice received on powers within existing legal framework, iro sanctions recommended by Select Committee • Meeting with Select Committee Chair, Norman Lamb
Making it easier to conduct high quality research in the UK • Technical Assurance - UK-wide QA procedure has been agreed and signed off • Sponsor- level IG standards - workshop to discuss held 16/11/18 • SoECAT - Published via NIHR website • CWOW – pilot progressing well, 24 applications received, 18 complete • Four Nations - Local Information Template plan in place • Four Nations - Scotland and NI have agreed to use HARP to record outcomes
Develop a pro-active, strategically focussed organisation • Stakeholder engagement continues (Wellcome, MHRA, TranspariMed, Ben Goldacre) • Engagement material (slide, speaking notes, Q&A) developed and tested • REC Chairs day - 5th Dec • Consent to use of tissue and data - findings and next steps presented to UK Biobank annual showcase - 27th Nov • Brexit - response submitted to MHRA consultation on no-deal legislation for clinical trials of drugs and devices
Capitalising on technological developments • New IRAS development progressing with the current focus on interfaces, some delays experienced due to enhanced interoperability • Electronic Review of REC documents - new devices have been tested • HRA response to DHSC’s Policy Proposal: Developing the Framework for Safe Introduction and Use of Digital Health and Care Technology submitted on 2nd Nov • IT Infrastructure strategy and roadmap signed off • New Learning Management System live - end Nov
Ensuring the HRA is governedeffectively and provides value for the tax payer
Ensuring the HRA is governedeffectively and provides value for the tax payer